Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ASTON BAY HOLDINGS LTD. We currently have 7 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
ASTON BAY HOLDINGS LTD
ASTON BAY HOLDINGS LTD
SP Angel – Morning View
25 Jan 17
Antofagasta (ANTO LN) – Q4 Production | ASA Resources Group (ASA LN) BUY, Target price 2.5p - INITIATION - Renaissance underway in Zimbabwe | Aston Bay Holdings (BAY CN) – David Broughton, expert in sediment-hosted deposits, joins Aston Bay as Chief Geologist | BHP Billiton (BLT LN) – H1 production and reduced copper production guidance | FinnAust Mining* (FAM LN) – BUY Target Price 15p - Ilmenite marketing advisor | Rambler Metals (RMM LN) – 2017 production guidance | Tethyan Resources (TETH LN) – Drilling results from the Rudnitza prospect in Serbia
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017